obesity drug news today october 2025 glp-1 KFF's survey of Medicaid officials found 16 state Medicaid programs covered GLP-1s for treatment as of 2025. Since then, four states (CA, NH, PA, SC) have ended coverage and NC Oral Obesity Drugs Market Size

Registries and RWE can fill holes

Individuals with Gastrointestinal Disorders Conditions such as Crohns disease, celiac disease, or those who have undergone weight loss surgery can affect the bodys ability to absorb B12

With Kozicare Skin Whitening Soap say goodbye to packaging issues fragrance concerns and quality doubts

Asthma Allergies Immune support Liver detoxification support Neuro-degenerative processes i.e

Allergic reactions: Rare but possible

[8] MBs MAO-A inhibition means that even drugs like bupropion, buspirone, or amphetamines (which increase monoamines like dopamine/norepinephrine) are risky to use concurrently, as unusual neurotoxic reactions or blood pressure spikes could occur